|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net income | |||||
| Reconciliation of net income to net cash provided by operating activities: | |||||
| Depreciation, amortization and accretion | |||||
| Amortization of deferred financing fees | |||||
| (Gain) loss on disposal of assets and impairment charges | |||||
| Loss on extinguishment of debt | |||||
| Gain on West Texas Sale | |||||
| Other non-cash, net | |||||
| Non-cash unit-based compensation expense | |||||
| Deferred income tax expense (benefit) | |||||
| Inventory valuation adjustments | |||||
| Equity in earnings of unconsolidated affiliates | |||||
| Accounts receivable | |||||
| Accounts receivable from affiliates | |||||
| Inventories, net | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accounts payable to affiliates | |||||
| Accrued expenses and other current liabilities | |||||
| Other non-current liabilities | |||||
| Proceeds from Equity Method Investment, Distribution | |||||
| Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES: | |||||
| Capital expenditures | |||||
| Payments to Acquire Businesses, Net of Cash Acquired | |||||
| NuStar Acquisition | |||||
| acquisitions of terminals and other assets | |||||
| Parkland Acquisition | |||||
| Cash Acquired from Acquisition | |||||
| Contributions to unconsolidated affiliate | |||||
| Proceeds from West Texas Sale | |||||
| Distributions from unconsolidated affiliates in excess of cumulative earnings | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Payment for (Proceeds from) Other Investing Activity | |||||
| Net cash provided by (used in) investing activities | |||||
| FINANCING ACTIVITIES: | |||||
| Senior notes borrowings | |||||
| GoZone Bonds | |||||
| Senior Notes | |||||
| Total senior notes borrowings | |||||
| Senior notes repayments | |||||
| GoZone Bonds | |||||
| Senior Notes | |||||
| Total senior notes repayments | |||||
| Credit Facility borrowings | |||||
| Credit Facility | |||||
| Total credit Facility borrowings | |||||
| Credit Facility repayments | |||||
| NuStar Acquisition | |||||
| Credit Facility | |||||
| Parkland Credit Facility | |||||
| Total credit Facility repayments | |||||
| Loan origination costs | |||||
| Proceeds from Issuance of Preferred Stock and Preference Stock | |||||
| Preferred units redemption | |||||
| Payments of Ordinary Dividends, Noncontrolling Interest | |||||
| Net cash provided by (used in) financing activities | |||||
| Cash and Cash Equivalents, Period Increase (Decrease), Total | |||||
| Lease assets obtained in exchange for new lease liabilities | |||||
| Change in note payable to affiliate | |||||
| Payable due to seller in acquisition | |||||
| Interest paid | |||||
| Income Tax Credits and Adjustments | |||||
| Cash paid for income taxes, net of refunds (excluding $47 million of federal tax credits purchased from non-governmental third parties in 2024) | |||||
| Stock Issued During Period, Value, Acquisitions | |||||
| Joint Venture Formation, Fair Value of Joint Venture | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period |
Loading...